Zymeworks (ZYME) Operating Leases (2021 - 2026)

Zymeworks has disclosed Operating Leases across 6 years of filings, most recently posting $13.8 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $13.8 million, down 25.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.8 million (down 25.33% YoY), and the FY2025 annual result was $18.3 million, down 1.44% from the prior year.
• Operating Leases came in at $13.8 million for Q1 2026 at Zymeworks, down from $18.3 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $29.9 million in Q3 2022 to a low of $13.8 million in Q1 2026.
• The 5-year median for Operating Leases is $20.3 million (2024), against an average of $21.8 million.
• Peak annual rise in Operating Leases reached 5.39% in 2024, while the deepest fall reached 30.72% in 2024.
• Zymeworks' Operating Leases stood at $28.1 million in 2022, then retreated by 4.9% to $26.8 million in 2023, then sank by 30.72% to $18.5 million in 2024, then dropped by 1.44% to $18.3 million in 2025, then fell by 24.66% to $13.8 million in 2026.
• The last three Operating Leases figures came in at $13.8 million (Q1 2026), $18.3 million (Q4 2025), and $18.9 million (Q3 2025), per Business Quant data.